Real-time enrollment status for this chronic inflammatory demyelinating polyneuropathy clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:01 PM UTC
| NCT Number | NCT06752356 |
| Recruiting Status | Recruiting |
| Condition | Chronic Inflammatory Demyelinating Polyneuropathy |
| Phase | PHASE3 |
| Target Enrollment | 161 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Kedrion S.p.A. |
| Last Updated on CT.gov | September 11, 2026 (Sep 11, 2026) |
As of October 15, 2026: Clinical trial NCT06752356 is currently recruiting participants. This phase3 study for chronic inflammatory demyelinating polyneuropathy is actively seeking new participants at 5 locations across the United States. The study is sponsored by Kedrion S.p.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06752356 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06752356 was last updated Sep 11, 2026 (September 11, 2026). HelloStudys verifies this status automatically.